Skin and Soft Tissue Infections Due to Methicillin-Resistant Staphylococcus aureus: Role of Tigecycline

被引：3

作者：

Curcio, Daniel ^{[1
]}

机构：

[1] Infectol Inst SRL, Inst Sacre Cour, Infect Dis Serv, RA-1419 Buenos Aires, Argentina

来源：

CLINICAL INFECTIOUS DISEASES | 2011年 / 52卷 / 12期

关键词：

D O I：

10.1093/cid/cir192

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1468 / U1401

页数：2

共 9 条

[1]

[Anonymous], FDA DRUG SAF COMM IN

[2] Tigecycline use in critically ill older patients:: Case reports and critical analysis [J].

Curcio, Daniel ;

Fernandez, Francisco ;

Duret, Fernando .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (02) :312-313

[3] The importance of bactericidal drugs: Future directions in infectious disease [J].

Finberg, RW ;

Moellering, RC ;

Tally, FP ;

Craig, WA ;

Pankey, GA ;

Dellinger, EP ;

West, MA ;

Joshi, M ;

Linden, PK ;

Rolston, KV ;

Rotschafer, JC ;

Rybak, MJ .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) :1314-1320

[4] Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci:: a Phase 3, multicentre, double-blind, randomized study [J].

Florescu, I. ;

Beuran, A. ;

Dimov, R. ;

Razbadauskas, A. ;

Bochan, M. ;

Fichev, G. ;

Dukart, G. ;

Babinchak, T. ;

Cooper, C. A. ;

Ellis-Grosse, E. J. ;

Dartois, N. ;

Gandjini, H. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 :I17-I28

[5] Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials [J].

Gardiner, David ;

Dukart, Gary ;

Cooper, Angel ;

Babinchak, Timothy .

CLINICAL INFECTIOUS DISEASES, 2010, 50 (02) :229-238

[6] Predicting Bacteremia among Patients Hospitalized for Skin and Skin-Structure Infections: Derivation and Validation of a Risk Score [J].

Lipsky, Benjamin A. ;

Kollef, Marin H. ;

Miller, Loren G. ;

Sun, Xiaowu ;

Johannes, Richard S. ;

Tabak, Ying P. .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (08) :828-837

[7]

Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI [10.1093/cid/cir034, 10.1093/cid/ciq146]

[8] Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers [J].

Mendes, Rodrigo E. ;

Sader, Helio S. ;

Deshpande, Lalitagauri ;

Jones, Ronald N. .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (04) :433-436

[9] Tigecycline: A critical analysis [J].

Stein, Gary E. ;

Craig, William A. .

CLINICAL INFECTIOUS DISEASES, 2006, 43 (04) :518-524

← 1 →